Stanley Laman Group Ltd. Invests $8.79 Million in Lam Research Corporation $LRCX

Stanley Laman Group Ltd. purchased a new position in Lam Research Corporation (NASDAQ:LRCX) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 65,637 shares of the semiconductor company’s stock, valued at approximately $8,789,000. Lam Research accounts for about 1.3% of Stanley Laman Group Ltd.’s investment portfolio, making the stock its 12th biggest position.

Several other institutional investors and hedge funds have also bought and sold shares of LRCX. IMG Wealth Management Inc. bought a new stake in shares of Lam Research in the second quarter valued at $26,000. Howard Hughes Medical Institute purchased a new stake in Lam Research in the 2nd quarter worth about $27,000. Sound Income Strategies LLC bought a new stake in Lam Research in the 3rd quarter valued at about $41,000. Tripletail Wealth Management LLC purchased a new stake in Lam Research during the third quarter valued at about $44,000. Finally, Strategic Wealth Investment Group LLC bought a new position in Lam Research during the second quarter worth about $29,000. 84.61% of the stock is owned by institutional investors.

Lam Research Price Performance

NASDAQ:LRCX opened at $185.06 on Monday. Lam Research Corporation has a 52-week low of $56.32 and a 52-week high of $185.78. The stock has a fifty day moving average of $161.34 and a 200 day moving average of $129.39. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21. The firm has a market capitalization of $232.44 billion, a price-to-earnings ratio of 40.76, a P/E/G ratio of 2.14 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last released its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company’s revenue was up 27.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, research analysts expect that Lam Research Corporation will post 3.71 EPS for the current fiscal year.

Lam Research Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 7th. Shareholders of record on Wednesday, December 3rd will be given a dividend of $0.26 per share. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 annualized dividend and a yield of 0.6%. Lam Research’s payout ratio is presently 22.91%.

Analyst Upgrades and Downgrades

LRCX has been the topic of several research reports. B. Riley boosted their price target on shares of Lam Research from $180.00 to $195.00 and gave the company a “buy” rating in a research report on Thursday, December 18th. Wall Street Zen cut shares of Lam Research from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Oppenheimer set a $200.00 target price on Lam Research and gave the stock an “outperform” rating in a research report on Thursday, October 23rd. TD Cowen lifted their price target on Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research report on Thursday, October 23rd. Finally, Sanford C. Bernstein boosted their price objective on Lam Research from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Friday, November 21st. Twenty-six equities research analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $161.21.

Insider Activity at Lam Research

In other Lam Research news, CFO Douglas R. Bettinger sold 40,080 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The shares were sold at an average price of $150.60, for a total value of $6,036,048.00. Following the completion of the transaction, the chief financial officer owned 987,237 shares of the company’s stock, valued at $148,677,892.20. The trade was a 3.90% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction on Monday, October 13th. The shares were sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. This trade represents a 17.21% decrease in their position. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 102,608 shares of company stock valued at $14,916,496. Company insiders own 0.31% of the company’s stock.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.